Browse articles from EyeWorld.org related to refractive surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Two cornea and refractive specialists discussed the most common reasons an IOL exchange may be needed and the initial diagnostic steps to rule out other reasons for poor quality vision. They shared pearls for performing these cases and the importance of having a comprehensive plan of attack.
In her introduction, Karolinne Rocha, MD, PhD, previewed the articles in the Refractive section and specifically shared some thoughts on the trends that may be causing a decline in LASIK procedures.
The future of corneal refractive surgery is in the works. EyeWorld checked in on various technologies in the pipeline with physicians in the know.
➤ Topline results from trial for biologic eye drop for dry eye ➤ First patient dosed in Phase 3 trial evaluating oral non-opioid sedation ➤ First patient dosed in retinitis pigmentosa gene therapy trial ➤ Clinical program for IOP-lowering drug discontinued ➤ ASCRS news and events
➤ FDA grants 510(k) indication expansion for MIGS tool ➤ FDA approves biosimilar for aflibercept ➤ De Novo Marketing Authorization granted for home OCT device ➤ Consensus guidelines for suprachoroidal drug delivery ➤ ASCRS news and events
➤ Topline results for investigational first-in-class dry eye drop ➤ Dosing complete in second cohort of Stargardt disease gene therapy trial ➤ Enrollment complete for Phase 2 acute optic neuritis trial ➤ Enrollment complete for Phase 1/2a trial evaluating neovascular AMD therapy ➤ ASCRS news and events
➤ CRISPR gene-editing trial shows ‘exciting potential’ ➤ Study: laser vision correction clinics missing opportunities ➤ Broad-based protection observed with investigational geographic atrophy therapy ➤ FDA accepts IND for diabetic macular edema therapy ➤ Phase 2 trial for non-proliferative diabetic retinopathy therapy does not meet primary endpoint ➤ ASCRS news and events
Among the important indications for use of the EVO ICL (STAAR Surgical)—age, amount of myopia, astigmatism correction, etc.—there is one parameter that some surgeons say could be causing confusion. Five of these surgeons discussed anterior chamber depth.
Refractive Editor Karolinne Rocha, MD, previewed the articles in the section and shared what she is looking forward to at the ASCRS Annual Meeting.
There has been controversy around ICL sizing and vault for a long time, according to some physicians. Three experts discussed the topic in this article.
Get the latest ophthalmology news delivered to your inbox every Friday.